Anticoagulation Therapy in the Very Old
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 70 - Any |
| Updated: | 2/7/2019 |
| Start Date: | March 20, 2017 |
| End Date: | September 2019 |
ATIVO Study - Anticoagulation Therapy in the Very Old
This study is designed to evaluate the efficacy and safety of warfarin anticoagulation in the
very old and attempt to identify risk factors which may impede safe and effective
anticoagulation.
very old and attempt to identify risk factors which may impede safe and effective
anticoagulation.
This is a prospective registry study with data being collected continuously for 24 months.
Patients who have electocardiographically confirmed atrial fibrillation, are being followed
by the Pen Bay Medical Center Anticoagulation Services and are at least 90 years old will be
recruited into the study. A matched cohort of patients between the ages of 80 and 89 and
another matched cohort of patients between the ages of 70 and 79 will also be recruited into
the study for comparison.
Data related to adverse events, concomitant medications, living arrangements, mobility and
alcohol use will be collected every 6 months. In addition the CHA2DS2-VASc, HAS - BLED,
frailty and Mini Cog scores will be recalculated at each visit.
Patients who have electocardiographically confirmed atrial fibrillation, are being followed
by the Pen Bay Medical Center Anticoagulation Services and are at least 90 years old will be
recruited into the study. A matched cohort of patients between the ages of 80 and 89 and
another matched cohort of patients between the ages of 70 and 79 will also be recruited into
the study for comparison.
Data related to adverse events, concomitant medications, living arrangements, mobility and
alcohol use will be collected every 6 months. In addition the CHA2DS2-VASc, HAS - BLED,
frailty and Mini Cog scores will be recalculated at each visit.
Inclusion Criteria:
- 70 years of age or older
- electrocardiographically confirmed atrial fibrillation
- anticipated regular follow up with patient by PBMC Anticoagulation Services
- Subject or legally authorized representative must be willing to provide informed
consent
Exclusion Criteria:
- Patients not being followed by the PBMC Anticoagulation Services
We found this trial at
1
site
Click here to add this to my saved trials
